Roy Ervin Twyman
Director/Board Member chez AC IMMUNE SA
Fortune : 101 084 $ au 31/03/2024
Profil
Roy Ervin Twyman is the founder of Amron Neuroscience LLC.
He is currently an Independent Non-Executive Director at AC Immune SA, a Director at NeuroVision Imaging LLC, and an Independent Director at Syndesi Therapeutics SA. Previously, he was the Senior Vice President-Neuroscience Therapeutic at Janssen Research & Development LLC from 2012 to 2018.
He received his undergraduate degree from the University of Kentucky.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AC IMMUNE SA
0,03% | 01/03/2024 | 34 150 ( 0,03% ) | 101 084 $ | 31/03/2024 |
Postes actifs de Roy Ervin Twyman
| Sociétés | Poste | Début |
|---|---|---|
| AC IMMUNE SA | Director/Board Member | 01/01/2019 |
NeuroVision Imaging LLC
 NeuroVision Imaging LLC Packaged SoftwareTechnology Services NeuroVision Imaging LLC develops digital imaging and diagnostic solutions for Alzheimer's disease and eye care markets. The firm offers CHARIOT:PRO, NVI0007, and A4. The company was founded by Keith L. Black, Maya Koronyo-Hamaoui, Yosef Koronyo, and Steven R. Verdooner in 2010 and is headquartered in Sacramento, CA. | Director/Board Member | 20/07/2018 |
| Amron Neuroscience LLC | Chief Executive Officer | - |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Director/Board Member | - |
Anciens postes connus de Roy Ervin Twyman
| Sociétés | Poste | Fin |
|---|---|---|
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01/03/2018 |
Formation de Roy Ervin Twyman
| University of Kentucky | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Entreprise privées | 4 |
|---|---|
NeuroVision Imaging LLC
NeuroVision Imaging LLC Packaged SoftwareTechnology Services NeuroVision Imaging LLC develops digital imaging and diagnostic solutions for Alzheimer's disease and eye care markets. The firm offers CHARIOT:PRO, NVI0007, and A4. The company was founded by Keith L. Black, Maya Koronyo-Hamaoui, Yosef Koronyo, and Steven R. Verdooner in 2010 and is headquartered in Sacramento, CA. | Technology Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Syndesi Therapeutics SA
Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Commercial Services |
| Amron Neuroscience LLC |
